Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132620) titled 'Efficacy and Safety of Polidocanol Injection Sclerotherapy for Axillary Osmidrosis: A Multicenter Real-World Study' on Sept. 16.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: Shanghai Tenth People's Hospital
Condition:
Axillary odor
Recruitment Status: Recruiting
Phase: 4
Date of First Enrollment: 2026-04-21
Target Sample Size: Experimental group:30;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=332284
Published by HT Digital Content Services with permission from Health Daily Digest....